D1和D2多巴胺受体激动剂及拮抗剂对慢性MPTP处理的猴子帕金森症的影响。 - Suppr | 超能文献

The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.

作者信息

Nomoto M, Fukuda T

机构信息

Department of Pharmacology, Kagoshima University, Japan.

出版信息

Adv Neurol. 1993;60:119-22.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

The effects of D1 and D2 dopamine receptor agonist and antagonist on parkinsonism in chronic MPTP-treated monkeys.D1和D2多巴胺受体激动剂及拮抗剂对慢性MPTP处理的猴子帕金森症的影响。

Adv Neurol. 1993;60:119-22.

2

Role of selective D1 and D2 agonists in inducing dyskinesia in drug-naive MPTP monkeys.选择性D1和D2激动剂在初治MPTP猴诱发运动障碍中的作用。

Adv Neurol. 1993;60:113-8.

3

Changes of D1 and D2 dopamine receptor mRNA in the brains of monkeys lesioned with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: correction with chronic administration of L-3,4-dihydroxyphenylalanine.1-甲基-4-苯基-1,2,3,6-四氢吡啶损伤的猴子大脑中多巴胺D1和D2受体mRNA的变化：长期给予L-3,4-二羟基苯丙氨酸的校正作用

Mol Pharmacol. 1996 Nov;50(5):1073-9.

4

N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.N-甲基-D-天冬氨酸受体拮抗剂与多巴胺D1和D2激动剂在1-甲基-4-苯基-1,2,5,6-四氢吡啶诱导的偏侧帕金森病猴中的相互作用

J Pharmacol Exp Ther. 1993 Jan;264(1):221-5.

5

Dyskinesia and wearing-off following dopamine D1 agonist treatment in drug-naive 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned primates.多巴胺D1激动剂治疗初治的1-甲基-4-苯基-1,2,3,6-四氢吡啶损伤灵长类动物后的运动障碍和药效减退。

Mov Disord. 1996 Jan;11(1):91-4. doi: 10.1002/mds.870110117.

6

The effects of chronic levodopa treatment on pre- and postsynaptic markers of dopaminergic function in striatum of parkinsonian monkeys.慢性左旋多巴治疗对帕金森病猴纹状体中多巴胺能功能的突触前和突触后标志物的影响。

Mov Disord. 1997 Mar;12(2):148-58. doi: 10.1002/mds.870120204.

7

The dopamine D1 agonist SKF 81297 and the dopamine D2 agonist LY 171555 act synergistically to stimulate motor behavior of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-lesioned parkinsonian rhesus monkeys.多巴胺 D1 激动剂 SKF 81297 与多巴胺 D2 激动剂 LY 171555 协同作用，刺激 1-甲基-4-苯基-1,2,3,6-四氢吡啶损伤的帕金森病恒河猴的运动行为。

Mov Disord. 1994 Nov;9(6):664-72. doi: 10.1002/mds.870090613.

8

Effect of adding the D1 agonist CY 208-243 to chronic bromocriptine treatment. I: Evaluation of motor parameters in relation to striatal catecholamine content and dopamine receptors.在慢性溴隐亭治疗中添加D1激动剂CY 208-243的效果。I：与纹状体儿茶酚胺含量和多巴胺受体相关的运动参数评估。

Mov Disord. 1993 Apr;8(2):144-50. doi: 10.1002/mds.870080205.

9

Chronic CY 208-243 treatment of MPTP-monkeys causes regional changes of dopamine and GABAA receptors.长期用CY 208-243治疗MPTP猴会导致多巴胺和GABAA受体的区域变化。

Neurosci Lett. 1993 Nov 26;163(1):31-5. doi: 10.1016/0304-3940(93)90222-7.

10

Dopamine D1 and D2 receptor interactions in the MPTP-treated marmoset.

Neurosci Lett. 1992 Aug 3;142(1):1-4. doi: 10.1016/0304-3940(92)90606-8.

引用本文的文献

1

Novel Dopamine Therapeutics for Cognitive Deficits in Schizophrenia.用于治疗精神分裂症认知缺陷的新型多巴胺疗法

Biol Psychiatry. 2017 Jan 1;81(1):67-77. doi: 10.1016/j.biopsych.2015.12.028. Epub 2016 Jan 18.